The Food and Drug Administration today announced that it will require class-wide changes to the labe...

Two devices for assessing cognitive function immediately following a suspected brain injury or concu...

As the number of hospitalizations for opioid misuse continues to grow, so too have questions of whet...

All-cause hospitalizations and deaths among veterans significantly increased following reductions in...

APA strongly supports the U.S. Food and Drug Administration’s proposed reclassification of electroco...

Twice-weekly high-dose unilateral electroconvulsive therapy (ECT) appears to be no less effective th...

Five years after it last broached the matter, the Food and Drug Administration (FDA) is again propos...

Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...

Yesterday, the Food and Drug Administration approved Addyi (flibanserin) to treat acquired, generali...